CN2 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Catalyst Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 27.3 EUR 2.63% Market Closed

Market Cap: €3.2B

C	Catalyst Pharmaceuticals Inc F:CN2	US
L	Lentex SA F:0KM	PL
	Alpha Lithium Corp F:765	CA
	Foraco International SA F:3F3	FR
C	Codex Acquisitions PLC LSE:CODX	UK

Profitability Summary

Catalyst Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

86%

Gross Margin is Increasing

86% > 86%

Exceptional Operating Margin

45%

Strong 3Y Average Operating Margin

35%

Declining Operating Margin

46% > 45%

Exceptional Net Margin

37%

Sustainable 3Y Average Net Margin

29%

Declining Net Margin

38% > 37%

Exceptional Free Cash Flow Margin

35%

Strong 3Y Average Free Cash Flow Margin

42%

Declining Free Cash Flow Margin

41% > 35%

Positive ROE

24%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

44%

Declining ROIC

72% > 57%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.